Abstract:Postoperative radiotherapy improves RFS and reduces the risk of local recurrence. The best results are obtained with early postoperative treatment ("adjuvant"); adjuvant radiotherapy of high-risk forms yields better results if performed with PSA less than or equal to 1 ng/ml.
“…The 5-year biochemical disease-free (bNED) rates range from 61.3% to 90.9% for the ART groups and 31% to 66.4% for the delayed therapy groups. Three series have reported superior 10-year bNED rates for the ART group compared with the SRT group: Teh and colleagues 7 with 90.9% versus 54.5% (p = 0.001), Caraffini and colleagues 8 with 38% versus 28% (p < 0.01) and Pacholke and colleagues 9 with 66% versus 22% (p < 0.001).…”
Section: Evidence From Nonrandomized Seriesmentioning
“…The 5-year biochemical disease-free (bNED) rates range from 61.3% to 90.9% for the ART groups and 31% to 66.4% for the delayed therapy groups. Three series have reported superior 10-year bNED rates for the ART group compared with the SRT group: Teh and colleagues 7 with 90.9% versus 54.5% (p = 0.001), Caraffini and colleagues 8 with 38% versus 28% (p < 0.01) and Pacholke and colleagues 9 with 66% versus 22% (p < 0.001).…”
Section: Evidence From Nonrandomized Seriesmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.